Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PBSerum Plus
- Development stage
- Preclinical
- Lead developer
- Proteos Biotech
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Intradermal, Intralesional, Subcutaneous, Topical
01
Overview
PBSerum Plus is a professional cosmeceutical and aesthetic line developed by Proteos Biotech, consisting of recombinant enzymes of bacterial origin. The line includes specific formulations such as Slim+ (containing Lipase PB500), Smooth+ (containing Collagenase GH PB220), and Drain+ (containing Hyaluronidase PB3000). These enzymes are produced using recombinant DNA technology in bacterial systems (such as *Thermus thermophilus*, *Clostridium histolyticum*, and *Streptococcus pyogenes*) to ensure high purity and substrate specificity. In clinical practice, these lyophilized enzymes are reconstituted and mixed in customized ratios to form a synergistic cocktail (often referred to as the PBSerum Triad) that targets the extracellular matrix. PBSerum Plus is used for tissue bioremodeling, addressing aesthetic and regenerative indications such as localized adiposity, cellulite, tissue fibrosis, skin laxity, subcutaneous nodules, and pathological scars.
- Brand names
- PBSerum Plus
- Other names
- PBSerum TriadPBSerum Triadapbserum Plus Drain+pbserum Plus Lift+pbserum Plus Slim+pbserum Plus Smooth+
Beyond the preview
Go deeper on PBSerum Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PBSerum Plus.